TY - JOUR
T1 - Non-medical switching of prescription medications, brand-name drugs and out-of-pocket spending on medicines among Peruvian adults
AU - Uyen-Cateriano, Angela
AU - Herrera-Añazco, Percy
AU - Mougenot, Benoit
AU - Benites-Meza, Jerry K.
AU - Benites-Zapata, Vicente A.
N1 - Publisher Copyright:
© 2021 The Author(s). Published by Oxford University Press on behalf of the Royal Pharmaceutical Society. All rights reserved.
PY - 2021/11/1
Y1 - 2021/11/1
N2 - Objectives: This study evaluated the association between non-medical switching of prescription medications (NMSPM) with brand-name drugs and out-of-pocket spending (OPS) on drugs among Peruvian adults. Methods: We conducted a secondary analysis of the National Survey of User Satisfaction Health using an analytical cross-sectional design. We included 3155 adults who went to drugstores and pharmacies with prescriptions. The independent variable was the self-reported NMSPM. The outcomes were brand-name drug purchase and OPS on drugs. We calculated crude and adjusted prevalence ratios (PR) with their respective 95% confidence intervals (CIs), and the OPS on drugs was analysed using linear regression with crude and adjusted β and their 95% CIs. Key findings: The rate of NMSPM was 6.7%, the proportion of brand-name drug purchases was 55.7% and the average spending on drugs was US$1.73. In the adjusted analysis, the proportion of brand-name drug purchases with NMSPM was higher than without (73.3% versus 54.5%; P < 0.001), with a statistically significant association (adjusted PR = 1.38; 95% CI = 1.29 to 1.47; P < 0.001), and the association between NMSPM and OPS on drugs was statistically significant (adjusted β = 0.23; 95% CI = 0.16 to 0.30; P < 0.001). Conclusions: There is a greater probability of brand-name drug purchases and OPS on drugs when NMSPM exists among adults who go to drugstores and pharmacies in Peru.
AB - Objectives: This study evaluated the association between non-medical switching of prescription medications (NMSPM) with brand-name drugs and out-of-pocket spending (OPS) on drugs among Peruvian adults. Methods: We conducted a secondary analysis of the National Survey of User Satisfaction Health using an analytical cross-sectional design. We included 3155 adults who went to drugstores and pharmacies with prescriptions. The independent variable was the self-reported NMSPM. The outcomes were brand-name drug purchase and OPS on drugs. We calculated crude and adjusted prevalence ratios (PR) with their respective 95% confidence intervals (CIs), and the OPS on drugs was analysed using linear regression with crude and adjusted β and their 95% CIs. Key findings: The rate of NMSPM was 6.7%, the proportion of brand-name drug purchases was 55.7% and the average spending on drugs was US$1.73. In the adjusted analysis, the proportion of brand-name drug purchases with NMSPM was higher than without (73.3% versus 54.5%; P < 0.001), with a statistically significant association (adjusted PR = 1.38; 95% CI = 1.29 to 1.47; P < 0.001), and the association between NMSPM and OPS on drugs was statistically significant (adjusted β = 0.23; 95% CI = 0.16 to 0.30; P < 0.001). Conclusions: There is a greater probability of brand-name drug purchases and OPS on drugs when NMSPM exists among adults who go to drugstores and pharmacies in Peru.
KW - Drugs
KW - Generic
KW - Health expenditures
KW - Peru
KW - Pharmacies
KW - Pharmacoepidemiology
KW - Treatment switching
UR - http://www.scopus.com/inward/record.url?scp=85125341939&partnerID=8YFLogxK
U2 - 10.1093/jphsr/rmab059
DO - 10.1093/jphsr/rmab059
M3 - Artículo
AN - SCOPUS:85125341939
VL - 12
SP - 492
EP - 501
JO - Journal of Pharmaceutical Health Services Research
JF - Journal of Pharmaceutical Health Services Research
SN - 1759-8885
IS - 4
ER -